Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU2-40P (RNA, U2 small nuclear 40, pseudogene) is a non-coding RNA pseudogene that derives from the U2 small nuclear RNA (snRNA) gene family[1]. U2 snRNA itself is an essential component of the spliceosome and plays a critical role in pre-mRNA splicing; however, as a pseudogene, RNU2-40P does not produce a functional RNA product and has no known biological function, protein product, or therapeutic relevance[1]. There are no documented roles in disease, drug interactions, or biomarker applications for this pseudogene variant. Context: - The “U2 small nuclear RNA” family (e.g., RNU2-2, RNU2-40P) is a group of RNAs involved in the essential function of splicing, but only the bona fide (functional) U2 genes carry out biological functions[2][3][4]. - The “pseudogene” status indicates RNU2-40P is a non-functional, inactive genomic copy and is not a receptor, enzyme, drug target, or biomarker. - No publications or databases describe RNU2-40P as implicated in disease or as a therapeutic target[1]. This conforms to the conventions requested: using the correct name, accurate molecular classification ("Pseudogene" or "Other"), and reporting null for all disease- or drug-related information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 40, pseudogene (RNU2-40P).